HOME >> BIOLOGY >> NEWS
JCI table of contents: June 21, 2007

el reveals that constant activation of AT1 leads to cardiac and renal fibrosis in spite of only a modest increase in blood pressure, and will be useful for investigating the role of angiotensin II in organs affected by some forms of human hypertension.

Title: Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice

Author Contact:

Eric Clauser
Institut Cochin, Paris, France
Phone : 33-153-73-27-50; Fax : 33-153-73-27-51; E-mail: clauser@cochin.inserm.fr

View the PDF of this article at: http://www.the-jci.org/article.php?id=28764


Physiology

Dietary phytochemicals regulate detoxification enzyme CYP1A1

Cytochrome P450 1A1 (CYP1A1) is a detoxification enzyme that plays an important role in the metabolism of dietary toxins and orally absorbed drugs. It can also produce highly carcinogenic metabolites from polycyclic aromatic hydrocarbons. In a study appearing online on June 21 in advance of publication in the July print issue of the Journal of Clinical Investigation, Frank Gonzalez and colleagues from the National Cancer Institute report that dietary phytochemicals regulate whole-body CYP1A1 expression via an arylhydrocarbon nuclear translocator (Arnt) dependent system in the gut. The authors examined mice bred to lack Arnt expression in the intestinal epithelium and found that CYP1A1 expression and activity was markedly elevated in almost all non-gut tissues. Interestingly CYP1A1 expression was lost if the mice were fed a synthetic purified diet. However, CYP1A1 expression was restored following the addition of the natural phytochemical indole-3-carbinol to the diet of these mice. The data suggest that an Arnt-dependent pathway in the gut has an important role in the regulation of CYP1A1 expression and the metabolism of
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
21-Jun-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: JCI table contents June

(Date:5/24/2013)... for medication against Alzheimer,s disease, scientists have focused among ... beta (A-beta). After all, it is the accumulation of A-beta ... patients. Starting point for the formation of A-beta is APP. ... to unravel the function of APPL the fruit-fly version ... , Alessia Soldano (VIB/KU Leuven): "We have discovered that ...
(Date:5/23/2013)... to be the world,s most popular fruit, can be ... with purple GM varieties. , "Working with GM ... the addition of a specific compound, allows us to ... Professor Cathie Martin from the John Innes Centre. , ... better flavour, health and shelf life characteristics because even ...
(Date:5/23/2013)... School of Public Health at Emory University, along ... have received a $4 million grant over four ... University (Health and Exposome Research Center: Understanding Lifetime ... grant awarded in the United States. , ... Institute of Environmental Health Sciences (NIEHS) of the ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2The world's favorite fruit only better-tasting and longer-lasting 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... May 23, 2013 BioTrends Research Group, ... firms for specialized biopharmaceutical issues, finds that, unaided, ... disease specialists reported that in the past six ... delaying treatment) in anticipation of the next generation ... ago, when only 6 percent reported that they ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
Cached News: